JPRN-UMIN000026042招募中未知
ong-term effects of dapagliflozin, a SGLT2 inhibitor, on glucose metabolism in patients with type 2 diabetes mellitus - Long-term effects of dapagliflozinon glucose metabolism in patients with diabetes mellitus
Kurume University School of Medicine0 个研究点目标入组 300 人开始时间: 2017年2月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Repeated urinary tract infection HbA1c < 7.0% BMI < 22
研究者
相似试验
进行中（未招募）
不适用
Impact of treatment with Dapagliflozin in type 1 diabetic patientsType 1 diabetesEUCTR2015-002963-40-ESDra Cristina Avendaño Sola
进行中（未招募）
1 期
Short-term effects of the substance dapagliflozin on the increase of blood sugar concentrations after meal and insulinsensitivity in type 1 diabetic patients.effects of Dapagliflozin on postprandial glucose excursion and fasting glucose homeostasisEUCTR2014-001441-24-ATMedical University Innsbruck12
尚未招募
不适用
Effect of SGLT2 inhibitor, Dapagliflozin combined with or without metformin on body composition in patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000030446St. Marianna University School of Medicine54
已完成
4 期
Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial InfarctionMyocardial InfarctionDiabete Type 2Glucose IntoleranceNCT05050500Qingdao Central Hospital143
已完成
1 期
Dapagliflozin Effects on HypoglycemiaType1 Diabetes MellitusNCT03704818University of California, San Diego22